A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants
Clinical trial NCT05686980 · COMPLETED
Trial details
- NCT number
- NCT05686980
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2023-03-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.